Mansel RE, Fallowfield L, Kissin M, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst. 2006;98(9):599–609. https://doi.org/10.1093/jnci/djj158.

Article  PubMed  Google Scholar 

Giuliano AE, Ballman KV, McCall L, et al. Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: The ACOSOG Z0011 (Alliance) randomized clinical trial. JAMA. 2017;318(10):918–26. https://doi.org/10.1001/jama.2017.11470.

Article  PubMed  PubMed Central  Google Scholar 

Krag DN, Anderson SJ, Julian TB, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010;11(10):927–33. https://doi.org/10.1016/S1470-2045(10)70207-2.

Article  PubMed  PubMed Central  Google Scholar 

Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol. 1993;2(6):335–9. https://doi.org/10.1016/0960-7404(93)90064-6.

Article  PubMed  CAS  Google Scholar 

Rocco N, Velotti N, Pontillo M, et al. New techniques versus standard mapping for sentinel lymph node biopsy in breast cancer: a systematic review and meta-analysis. Updates Surg. 2023;75(6):1699–710. https://doi.org/10.1007/s13304-023-01560-1.

Article  PubMed  PubMed Central  Google Scholar 

Ahmed M, Purushotham AD, Douek M. Novel techniques for sentinel lymph node biopsy in breast cancer: a systematic review. Lancet Oncol. 2014;15(8):e351–62. https://doi.org/10.1016/S1470-2045(13)70590-4.

Article  PubMed  Google Scholar 

White V, Harvey JR, Griffith CD, Youssef M, Carr M. Sentinel lymph node biopsy in early breast cancer surgery—working with the risks of vital blue dye to reap the benefits. Eur J Surg Oncol. 2011;37(2):101–8. https://doi.org/10.1016/j.ejso.2010.12.007.

Article  PubMed  CAS  Google Scholar 

Ghilli M, Carretta E, Di Filippo F, et al. The superparamagnetic iron oxide tracer: a valid alternative in sentinel node biopsy for breast cancer treatment. Eur J Cancer Care (Engl). 2017. https://doi.org/10.1111/ecc.12385.

Article  PubMed  Google Scholar 

Karakatsanis A, Christiansen PM, Fischer L, et al. The Nordic SentiMag trial: a comparison of super paramagnetic iron oxide (SPIO) nanoparticles versus Tc(99) and patent blue in the detection of sentinel node (SN) in patients with breast cancer and a meta-analysis of earlier studies. Breast Cancer Res Treat. 2016;157(2):281–94. https://doi.org/10.1007/s10549-016-3809-9.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Karakatsanis A, Daskalakis K, Stalberg P, et al. Superparamagnetic iron oxide nanoparticles as the sole method for sentinel node biopsy detection in patients with breast cancer. Br J Surg. 2017;104(12):1675–85. https://doi.org/10.1002/bjs.10606.

Article  PubMed  CAS  Google Scholar 

Rubio IT, Rodriguez-Revuelto R, Espinosa-Bravo M, Siso C, Rivero J, Esgueva A. A randomized study comparing different doses of superparamagnetic iron oxide tracer for sentinel lymph node biopsy in breast cancer: The SUNRISE study. Eur J Surg Oncol. 2020;46(12):2195–201. https://doi.org/10.1016/j.ejso.2020.06.018.

Article  PubMed  Google Scholar 

Thill M, Kurylcio A, Welter R, et al. The Central-European SentiMag study: sentinel lymph node biopsy with superparamagnetic iron oxide (SPIO) vs. radioisotope. Breast. 2014;23(2):175–9. https://doi.org/10.1016/j.breast.2014.01.004.

Article  PubMed  Google Scholar 

Pantiora E, Tasoulis MK, Valachis A, et al. Evolution and refinement of magnetically guided sentinel lymph node detection in breast cancer: meta-analysis. Br J Surg. 2023;110(4):410–9. https://doi.org/10.1093/bjs/znac426.

Article  PubMed  Google Scholar 

Warnberg F, Stigberg E, Obondo C, et al. Long-term outcome after retro-areolar versus peri-tumoral injection of superparamagnetic iron oxide nanoparticles (SPIO) for sentinel lymph node detection in breast cancer surgery. Ann Surg Oncol. 2019;26(5):1247–53. https://doi.org/10.1245/s10434-019-07239-5.

Article  PubMed  PubMed Central  Google Scholar 

Jazrawi A, Warnberg M, Hersi AF, et al. A comparison of skin staining after sentinel lymph node biopsy in women undergoing breast cancer surgery using blue dye and superparamagnetic iron oxide nanoparticle (SPIO) tracers. Cancers (Basel). 2022. https://doi.org/10.3390/cancers14236017.

Article  PubMed  PubMed Central  Google Scholar 

Christenhusz A, Pouw JJ, Simonis FFJ, et al. Breast MRI in patients after breast conserving surgery with sentinel node procedure using a superparamagnetic tracer. Eur Radiol Exp. 2022;6(1):3. https://doi.org/10.1186/s41747-021-00257-7.

Article  PubMed  PubMed Central  Google Scholar 

Researchmanager. Electronic data management and collection system. https://my-researchmanager.com/en/home-en/

Douek M, Klaase J, Monypenny I, et al. Sentinel node biopsy using a magnetic tracer versus standard technique: the SentiMAG Multicentre Trial. Ann Surg Oncol. 2014;21(4):1237–45. https://doi.org/10.1245/s10434-013-3379-6.

Article  PubMed  Google Scholar 

Ahmed M, Anninga B, Goyal S, Young P, Pankhurst QA, Douek M. Magnetic sentinel node and occult lesion localization in breast cancer (MagSNOLL Trial). Br J Surg. 2015;102(6):646–52. https://doi.org/10.1002/bjs.9800.

Article  PubMed  CAS  Google Scholar 

Karakatsanis A, Christiansen PM, Fischer L, et al. The Nordic SentiMag trial: a comparison of super paramagnetic iron oxide (SPIO) nanoparticles versus Tc(99) and patent blue in the detection of sentinel node (SN) in patients with breast cancer and a meta-analysis of earlier studies. Breast Cancer Res Treatment. 2016;157(2):281–94. https://doi.org/10.1007/s10549-016-3809-9.

Article  CAS  Google Scholar 

Karakatsanis A, Daskalakis K, Stålberg P, et al. Superparamagnetic iron oxide nanoparticles as the sole method for sentinel node biopsy detection in patients with breast cancer. Br J Surg. 2017;104(12):1675–85. https://doi.org/10.1002/bjs.10606.

Article  PubMed  CAS  Google Scholar 

Karakatsanis A, Olofsson H, Stålberg P, Bergkvist L, Abdsaleh S, Wärnberg F. Simplifying logistics and avoiding the unnecessary in patients with breast cancer undergoing sentinel node biopsy. A prospective feasibility trial of the preoperative injection of super paramagnetic iron oxide nanoparticles. Scand J Surg. 2018;107(2):130–7. https://doi.org/10.1177/1457496917738867.

Article  PubMed  CAS  Google Scholar 

Hersi AF, Pistiolis L, Dussan Luberth C, et al. Optimizing dose and timing in magnetic tracer techniques for sentinel lymph node detection in early breast cancers: The prospective multicenter SentiDose trial. Cancers (Basel). 2021. https://doi.org/10.3390/cancers13040693.

Article  PubMed  PubMed Central  Google Scholar 

Mirzaei N, Wärnberg F, Zaar P, Leonhardt H, Olofsson BR. Ultra-low dose of superparamagnetic iron oxide nanoparticles for sentinel lymph node detection in patients with breast cancer. Ann Surg Oncol. 2023. https://doi.org/10.1245/s10434-023-13722-x.

Article  PubMed  PubMed Central  Google Scholar 

Christenhusz A, Dassen AE, van der Schaaf MC, et al. Magnetic procedure for sentinel lymph node detection and evaluation of metastases: design and rationale of the Lowmag trial. BMC Methods. 2024;1(1):6. https://doi.org/10.1186/s44330-024-00006-3.

Article  Google Scholar 

Nieuwenhuis ER, Kolenaar B, Hof JJ, et al. A comprehensive grading system for a magnetic sentinel lymph node biopsy procedure in head and neck cancer patients. Cancers (Basel). 2022. https://doi.org/10.3390/cancers14030678.

Article  PubMed  PubMed Central  Google Scholar 

Sadaf Salamzadeh AC, Lejla Alic. Data from: Look-up table for assessment of iron content in Magtrace® samples based on Sentimag® 2023. 4TU.ResearchData. https://doi.org/10.4121/2ad11693-4d07-488f-936e-a3d4d9430ae0

Alic L. Iron calculator. Magnetic detection and imaging group - University of Twente. Accessed November 28, 2023. http://ironcalculator.utwente.nl/

Alvarado MD, Mittendorf EA, Teshome M, et al. Correction to: SentimagIC: a non-inferiority trial comparing superparamagnetic iron oxide versus technetium-99m and blue dye in the detection of axillary sentinel nodes in patients with early-stage breast cancer. Ann Surg Oncol. 2020;27(Suppl 3):979. https://doi.org/10.1245/s10434-020-08688-z.

Article  PubMed  Google Scholar 

Team R. RStudio: Integrated development for R. RStudio. PBC. http://www.rstudio.com/.

Yi M, Meric-Bernstam F, Ross MI, et al. How many sentinel lymph nodes are enough during sentinel lymph node dissection for breast cancer? Cancer. 2008;113(1):30–7. https://doi.org/10.1002/cncr.23514.

Article  PubMed